Madam Chair, when developing our plans, we looked closely at risk mitigation measures. We considered a host of factors that could come into play, such as a warehouse or a production site potentially being compromised.
Of course, we did not anticipate Pfizer's announcement to have such an impact, and for a period of four weeks. That has a fairly significant short-term impact on distribution, and I realize how disappointing it is and to what extent clinics are suffering the consequences. However, everything leads us to believe that we will be able to considerably increase the distribution over the next few weeks.